Suppr超能文献

合成和评价 2,5-取代嘧啶作为小分子结合物。

Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin binders.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, St. John's University, Queens, NY 11439, USA.

Gustaf H. Carlson School of Chemistry & Biochemistry, Clark University, Worcester, MA 01610, USA.

出版信息

Future Med Chem. 2024 Feb;16(3):239-251. doi: 10.4155/fmc-2023-0124. Epub 2024 Jan 11.

Abstract

Gankyrin is an ankyrin-repeat protein that promotes cell proliferation, tumor development and cancer progression when overexpressed. To design and synthesize a novel series of gankyrin-binding small molecules predicated on a 2,5-pyrimidine scaffold. The synthesized compounds were evaluated for their antiproliferative activity, ability to bind gankyrin and effects on cell cycle progression and the proteasomal degradation pathway. Compounds and demonstrated the most potent antiproliferative activity against MCF7 and A549 cells, respectively. Both compounds also demonstrated the ability to effectively bind gankyrin, disrupt proteasomal degradation and inhibit cell cycle progression. The 2,5-pyrimidine scaffold exhibits a novel and promising strategy for binding gankyrin and inhibiting cancer cell proliferation.

摘要

Gankyrin 是一种锚蛋白重复蛋白,当过度表达时,可促进细胞增殖、肿瘤发展和癌症进展。设计并合成了一系列基于 2,5-嘧啶骨架的新型 Gankyrin 结合小分子。评估了合成化合物的抗增殖活性、与 Gankyrin 结合的能力以及对细胞周期进程和蛋白酶体降解途径的影响。化合物 和 分别对 MCF7 和 A549 细胞表现出最强的抗增殖活性。这两种化合物还都具有有效结合 Gankyrin、破坏蛋白酶体降解和抑制细胞周期进程的能力。2,5-嘧啶骨架为结合 Gankyrin 和抑制癌细胞增殖提供了一种新颖而有前途的策略。

相似文献

1
Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin binders.
Future Med Chem. 2024 Feb;16(3):239-251. doi: 10.4155/fmc-2023-0124. Epub 2024 Jan 11.
2
The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.
Cell Cycle. 2005 Oct;4(10):1335-7. doi: 10.4161/cc.4.10.2107. Epub 2005 Oct 17.
4
The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
Cancer Cell. 2005 Jul;8(1):75-87. doi: 10.1016/j.ccr.2005.06.006.
6
Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer.
J Med Chem. 2022 Jul 14;65(13):8975-8997. doi: 10.1021/acs.jmedchem.2c00190. Epub 2022 Jun 27.
7
Functional characterization of human oncoprotein gankyrin in Zebrafish.
Exp Mol Med. 2009 Jan 31;41(1):8-16. doi: 10.3858/emm.2009.41.1.002.
8
Structural modification of the aryl sulfonate ester of cjoc42 for enhanced gankyrin binding and anti-cancer activity.
Bioorg Med Chem Lett. 2020 Feb 15;30(4):126889. doi: 10.1016/j.bmcl.2019.126889. Epub 2019 Dec 16.
10
Gankyrin, the 26 S proteasome, the cell cycle and cancer.
Biochem Soc Trans. 2006 Nov;34(Pt 5):746-8. doi: 10.1042/BST0340746.

本文引用的文献

2
Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer.
Cancers (Basel). 2022 Jun 22;14(13):3068. doi: 10.3390/cancers14133068.
3
Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer.
J Med Chem. 2022 Jul 14;65(13):8975-8997. doi: 10.1021/acs.jmedchem.2c00190. Epub 2022 Jun 27.
4
Identification of novel gankyrin binding scaffolds by high throughput virtual screening.
Bioorg Med Chem Lett. 2021 Jul 1;43:128043. doi: 10.1016/j.bmcl.2021.128043. Epub 2021 Apr 16.
7
Gankyrin Oncoprotein: Structure, Function, and Involvement in Cancer.
Curr Chem Biol. 2010;4(1):13-19. doi: 10.2174/2212796811004010013.
10
Gankyrin promotes osteosarcoma tumorigenesis by forming a positive feedback loop with YAP.
Cell Signal. 2020 Jan;65:109460. doi: 10.1016/j.cellsig.2019.109460. Epub 2019 Oct 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验